Abstract
Objective To study the efficacy and safety of hepatic arterial infusion of Endostatin (YH-16, Endostar), combined with transcatheter arterial chemoembolization (TACE) on advanced hepatocellular carcinoma.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have